[Controlled trial of the trimethoprim-sulfamethoxazole combination in acute and chronic reactivated infections of the respiratory tract].
D000208:Acute Disease; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004357:Drug Synergism; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Sperimentazione controllata dell'associazione trimethoprim-sulfametossazolo nelle infezioni acute e croniche riacutizzate dell'apparato respiratorio.